The Australian Familial Pancreatic Cancer Cohort (AFPaCC) targets the relatively small group of pancreatic cancer cases considered to be familial or hereditary. The registry captures information on individuals and families with a strong history of pancreatic cancer and searches for any gene mutations which may correlate to this predisposition. The registry may also help to identify candidates eligible to become involved in a current research trial screening high risk individuals.
If you and your family would like to be part of the battle against Pancreatic Cancer, please enter your details below. You may be eligible to join the APGI's Australian Familial Pancreatic Cancer Cohort, a registry targeting families considered to be at an increased risk.
Early detection and treatment of pancreatic cancer can drastically improve survival. Therefore screening individuals considered to be at a high risk of developing pancreatic cancer may be worthwhile. A screening trial has commenced, and is currently recruiting eligible high risk candidates. Involvement in the study may not only benefit your health, it could also predict cancer risk to family members and help to establish an effective pancreatic screening protocol in Australia.